These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 31651200)

  • 21. Liquid biopsy: Circulating exosomal long noncoding RNAs in cancer.
    Jiang N; Pan J; Fang S; Zhou C; Han Y; Chen J; Meng X; Jin X; Gong Z
    Clin Chim Acta; 2019 Aug; 495():331-337. PubMed ID: 31054913
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Current and future perspectives of liquid biopsies in genomics-driven oncology.
    Heitzer E; Haque IS; Roberts CES; Speicher MR
    Nat Rev Genet; 2019 Feb; 20(2):71-88. PubMed ID: 30410101
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Advances in Cancer Therapy: Liquid Biopsy.
    Marmé D
    Oncol Res Treat; 2017; 40(7-8):402-403. PubMed ID: 28728143
    [No Abstract]   [Full Text] [Related]  

  • 24. [Circulating Tumor DNA (ctDNA) Detection Using BEAMing and Its Clinical Significance.].
    Nakamura K
    Rinsho Byori; 2016 May; 64(4):400-406. PubMed ID: 29182806
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Circulating tumor DNA (ctDNA) is not a good proxy for liquid biopsies of tumor tissues for early detection.
    Fiala C; Diamandis EP
    Clin Chem Lab Med; 2020 Sep; 58(10):1651-1653. PubMed ID: 32160156
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Liquid Biopsy: Current Status and Future Perspectives.
    Mader S; Pantel K
    Oncol Res Treat; 2017; 40(7-8):404-408. PubMed ID: 28693023
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Extracellular Vesicles in Cancer Detection: Hopes and Hypes.
    Hu T; Wolfram J; Srivastava S
    Trends Cancer; 2021 Feb; 7(2):122-133. PubMed ID: 33008796
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Detection of incipient tumours by screening of circulating plasma DNA: hype or hope?
    Lenaerts L; Tuveri S; Jatsenko T; Amant F; Vermeesch JR
    Acta Clin Belg; 2020 Feb; 75(1):9-18. PubMed ID: 31578135
    [No Abstract]   [Full Text] [Related]  

  • 29. A New Horizon in Cancer Care: Liquid Biopsy.
    Copur M
    Oncology (Williston Park); 2021 Dec; 35(12):798-799. PubMed ID: 35089002
    [No Abstract]   [Full Text] [Related]  

  • 30. Circulating Tumour Cells in Predictive Molecular Pathology: Focus on Drug-Sensitive Assays and 3D Culture.
    Pallante P; Pisapia P; Bellevicine C; Malapelle U; Troncone G
    Acta Cytol; 2019; 63(3):171-181. PubMed ID: 30759433
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Liquid biopsy: unlocking the potentials of cell-free DNA.
    Chu D; Park BH
    Virchows Arch; 2017 Aug; 471(2):147-154. PubMed ID: 28466157
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Incorporating BEAMing technology as a liquid biopsy into clinical practice for the management of colorectal cancer patients: an expert taskforce review.
    García-Foncillas J; Alba E; Aranda E; Díaz-Rubio E; López-López R; Tabernero J; Vivancos A
    Ann Oncol; 2017 Dec; 28(12):2943-2949. PubMed ID: 28945877
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Liquid biopsy in newly diagnosed patients with locoregional (I-IIIA) non-small cell lung cancer.
    Chen K; Kang G; Zhao H; Zhang K; Zhang J; Yang F; Wang J
    Expert Rev Mol Diagn; 2019 May; 19(5):419-427. PubMed ID: 30905203
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Circulating Tumour DNA in Muscle-Invasive Bladder Cancer.
    Tan MP; Attard G; Huddart RA
    Int J Mol Sci; 2018 Aug; 19(9):. PubMed ID: 30158468
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Liquid biopsy in head and neck squamous cell carcinoma: Prognostic significance of circulating tumor cells and circulating tumor DNA. A systematic review.
    Lauritano D; Oberti L; Gabrione F; Lucchese A; Petruzzi M; Carinci F; Lo Muzio L
    Oral Oncol; 2019 Oct; 97():7-17. PubMed ID: 31421474
    [No Abstract]   [Full Text] [Related]  

  • 36. Circulating tumor DNA profiling for childhood brain tumors: Technical challenges and evidence for utility.
    Liu AP; Northcott PA; Robinson GW; Gajjar A
    Lab Invest; 2022 Feb; 102(2):134-142. PubMed ID: 34934181
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Circulating tumor DNA: a promising biomarker in the liquid biopsy of cancer.
    Cheng F; Su L; Qian C
    Oncotarget; 2016 Jul; 7(30):48832-48841. PubMed ID: 27223063
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Single tube liquid biopsy for advanced non-small cell lung cancer.
    de Wit S; Rossi E; Weber S; Tamminga M; Manicone M; Swennenhuis JF; Groothuis-Oudshoorn CGM; Vidotto R; Facchinetti A; Zeune LL; Schuuring E; Zamarchi R; Hiltermann TJN; Speicher MR; Heitzer E; Terstappen LWMM; Groen HJM
    Int J Cancer; 2019 Jun; 144(12):3127-3137. PubMed ID: 30536653
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Liquid Biopsy: A New Tool in Oncology.
    Costa JL; Schmitt FC
    Acta Cytol; 2019; 63(6):448. PubMed ID: 31266005
    [No Abstract]   [Full Text] [Related]  

  • 40. Current Status of Circulating Tumor DNA Liquid Biopsy in Pancreatic Cancer.
    Grunvald MW; Jacobson RA; Kuzel TM; Pappas SG; Masood A
    Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33081107
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.